Bridged aza-bicyclic derivatives as substance P antagonist
申请人:Pfizer Inc.
公开号:US05498614A1
公开(公告)日:1996-03-12
The invention relates to bridged aza-bicyclic derivatives of formula (I). These compounds are useful in the treatment of inflammatory and central nervous system disorders, as well as other disorders. Also disclosed are intermediates used in the synthesis of compound of formula (I). ##STR1##